Since the beginning of 2023, a large number of domestic and foreign pharmaceutical companies have disclosed their 2022 annual performance forecasts
.
In China, as of January 11, about 20 pharmaceutical companies in the pharmaceutical industry have released 2022 performance reports and performance forecasts
.
For example, East Asia Pharmaceutical released its 2022 performance report on the evening of January 10, and the company expects to achieve operating income of 1.
180 billion yuan in 2022, a year-on-year increase of 65.
62%; The net profit attributable to the parent was 104 million yuan, a year-on-year increase of 51.
58%.
In addition, Guizhou Sanli is expected to achieve a net profit attributable to the owner of the parent company of 196 million yuan ~ 217 million yuan in 2022, an increase of 43.
7174 million yuan ~ 64.
7174 million yuan over the previous year, a year-on-year increase of 28.
71% ~ 42.
5%; Dongxing Medical is expected to achieve a net profit of 120 million yuan to 130 million yuan in 2022, an increase of 8.
84% to 17.
91%; Enhua Pharmaceutical is expected to achieve a net profit of 837.
66 million yuan to 997.
21 million yuan in 2022, an increase of 5% to 25%.
.
.
.
.
.
Among the large number of pharmaceutical companies with good performance, some companies have also increased their net profits very gratifyingly
.
For example, Shanghai Yizhong expects the net profit attributable to shareholders of listed companies from January to December 2022 to be 150 million ~ 160 million, an increase of 3852.
72% ~ 4102.
9%
over the previous year.
In addition, Jardine Jardine Jiaye, Chuanning Biotechnology, Dongbao Biotechnology, Jincheng Pharmaceutical, Anke Biotechnology, etc.
are also expected to increase their net profit by more than 100%
in 2022.
It is worth noting that in the context of pharmaceutical companies disclosing their 2022 results one after another, some companies have also begun to look forward to 2023 results
.
For example, Illumina, the global manufacturer of gene sequencing instruments, recently announced a downward revision of its 2023 performance guidance, which was lower than market expectations
.
The company expects revenue to reach $4.
99 billion to $5.
03 billion this year, up 7% to 10% year-over-year, below the consensus expectation of about
11% year-over-year growth.
Illumina expects its non-GAAP operating margin to remain around 8% and adjusted earnings per share of $1.
25 to $1.
50 in 2023, also below the consensus expectation of $3.
10
.
On January 10, GE Healthcare said that based on preliminary results, fourth-quarter revenue increased about 7% year-over-year to $4.
9 billion, and organic revenue increased about 12%
year-over-year.
Full-year 2022 revenue increased approximately 4% year-over-year to approximately $18.
3 billion, and full-year organic revenue increased approximately 7%
year-over-year.
Looking ahead to 2023, GE expects organic revenue to grow 5% to 7%
year-over-year.
Adjusted EBIT was 15.
0% to 15.
5%, an expansion of 50 basis points to 100 basis points from the 2022 Forward Adjusted EBITDA and expects a free cash flow conversion rate of more than
85%.
In general, in recent years, the pharmaceutical industry is showing a continuous development trend, and at the same time, the performance of most pharmaceutical companies is also growing
.
It is expected that in the future, with the acceleration of population aging and the sound medical insurance system and other factors, China's demand for drugs will continue to increase, the pharmaceutical industry will grow rapidly, affected by this, the overall performance of domestic pharmaceutical enterprises will continue to develop
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
